![Brenda McCormack](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Brenda McCormack
Nessuna posizione attualmente
Storia della carriera di Brenda McCormack
Precedenti posizioni note di Brenda McCormack
Società | Posizione | Inizio | Fine |
---|---|---|---|
Xenetic Biosciences (UK) Ltd.
![]() Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 17/11/2010 | - |
Formazione di Brenda McCormack
University College Dublin | Undergraduate Degree |
University of London | Doctorate Degree |
Statistiche
Distribuzione geografica
Regno Unito | 3 |
Irlanda | 2 |
Posizioni
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Settori
Consumer Services | 3 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Xenetic Biosciences (UK) Ltd.
![]() Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Brenda McCormack
- Esperienza